TETRAPHASE PHARMACEUTICALS INC 4
4 · TETRAPHASE PHARMACEUTICALS INC · Filed Jan 8, 2016
Insider Transaction Report
Form 4
Horn Patrick Taylor
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2016-01-06+100,000→ 100,000 totalExercise: $8.47Exp: 2026-01-05→ Common Stock (100,000 underlying) - Award
Restricted Stock Units
2016-01-06+35,000→ 35,000 totalExercise: $0.00→ Common Stock (35,000 underlying)
Footnotes (3)
- [F1]Vests as to 6.25% of the shares on 4/6/2016 and further vests as to an additional 6.25% of the original grant at the end of each successive three-month period thereafter until 1/6/2020.
- [F2]Each restricted stock unit represents a contingent right to receive one share of common stock of Tetraphase Pharmaceuticals, Inc. for no consideration.
- [F3]The restricted stock units vest in three equal installments on each of January 6, 2017, January 6, 2018 and January 6, 2019.